首页> 外文期刊>American Journal of Infection Control >Infections in solid-organ transplant recipients
【24h】

Infections in solid-organ transplant recipients

机译:实体器官移植受者中的感染

获取原文
获取原文并翻译 | 示例
       

摘要

Despite remarkable progress and dramatic improvement in surgical techniques, immunosup-pressive therapy, and postoperative management, infections remain a significant complication and a major cause of death after transplantation. The spectrum of infectious complications in organ transplant recipients, however, has continued to evolve. For example, a decrease in cytomegalo-virus (CMV)-associated deaths (attributable largely to effective therapy and improved prophylaxis) and a marked decline in the incidence of Pneumocystis carinii pneumonia (as a result of routine use of prophylaxis) have been documented in recent years. In contrast, the incidence of infections caused by gram-positive cocci (van-comycin-resistant enterococci and methicillin-resistant Staphylococcus aureus) has increased, and opportunistic mycoses (e.g., invasive asper-gillosis) continue to be associated with very high mortality rates. New (or previously unrecognized) pathogens have also been reported in transplant recipients. This report is an overview of the current knowledge of infections in organ transplant recipients with emphasis on advances in diagnosis and prevention.
机译:尽管在外科技术,免疫抑制治疗和术后处理方面取得了显着进步和显着改善,但感染仍然是重要的并发症,并且是移植后死亡的主要原因。然而,器官移植受者中感染并发症的范围仍在继续发展。例如,已在文献中记录了巨细胞病毒(CMV)相关死亡人数的减少(主要归因于有效的治疗和预防措施的改善)以及卡氏肺孢子虫性肺炎的发生率的显着下降(作为常规预防措施的结果)。最近几年。相反,由革兰氏阳性球菌(耐万古霉素的肠球菌和耐甲氧西林的金黄色葡萄球菌)引起的感染发生率增加,机会性真菌病(例如侵袭性曲霉病)继续与极高的死亡率相关。还已经在移植接受者中报告了新的(或以前无法识别的)病原体。本报告概述了器官移植受者当前的感染知识,重点是诊断和预防方面的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号